Maravai LifeSciences
Supplies nucleic-acid tools and biologics testing products for therapies, vaccines, diagnostics, and research.
$7.79
After-hours close+0.13 (+1.74%)
At close$7.66(−8.54%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 83.69%121.43M sharesInsiders 6.18%8.97M sharesOther 10.13%14.70M shares
Shares outstanding 145.10M · Float 101.51M · 70.0% free float
Institutions13F, as of Mar 31, 2026
165 holders · 121.43M shares · 26 new positions · 79 increased · 53 reduced · 30 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| GTCR LLC | 20.15M | 13.89% | 0 | May 15, 2026 |
| Braidwell LP | 10.24M | 7.06% | +1.89M | May 15, 2026 |
| BlackRock, Inc. | 9.35M | 6.44% | −33.2K | May 13, 2026 |
| 12 West Capital Management LP | 7.26M | 5.00% | −1.66M | May 15, 2026 |
| Mackenzie Financial Corp | 6.31M | 4.35% | +132.8K | May 13, 2026 |
| Vanguard Capital Management LLC | 5.45M | 3.76% | +5.45Mnew | May 15, 2026 |
| Renaissance Technologies LLC | 4.26M | 2.94% | +39.6K | May 14, 2026 |
| Tejara Capital Ltd | 3.50M | 2.41% | +475.0K | May 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 5.90% | 8.58M | 13G | Oct 17, 2025 ↗ |
| Hudson View Holdings LLC | 5.01% | 7.34M | 13G | May 14, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Bernd Brust | director, officer: Chief Executive Officer | 2.06M | 1.42% | Aug 11, 2026 |
| William E. Iii Martin | officer: Chief Executive Officer | 1.81M | 1.25% | Mar 19, 2025 |
| Peter Michael Leddy | officer: See Remarks | 727.2K | 0.50% | Jul 16, 2025 |
| Kevin Herde | officer: Chief Financial Officer | 674.6K | 0.46% | May 28, 2025 |
| Rajesh Asarpota | officer: Chief Financial Officer | 429.0K | 0.30% | Aug 3, 2026 |
| Christine Dolan | officer: See Remarks | 425.3K | 0.29% | May 22, 2026 |
| R. Andrew Eckert | director | 412.2K | 0.28% | May 28, 2026 |
| Kurt Oreshack | officer: General Counsel | 335.8K | 0.23% | Jun 10, 2026 |
| Gregory T. Lucier | director | 311.2K | 0.21% | Jun 10, 2026 |
| Rebecca Buzzeo | officer: See Remarks | 310.9K | 0.21% | Mar 19, 2025 |
7 people have not refiled in the last 18 months (131.50M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 10, 2026 | Kurt Oreshackofficer: General Counsel | Sale | 25,000 | $5.10 | 335,767 |
| Jun 9, 2026 | Kurt Oreshackofficer: General Counsel | Sale | 25,000 | $5.06 | 360,767 |
| Dec 5, 2025 | Gregory T. Lucierdirector | Purchase | 51,472 | $3.70 | 106,595 |
| Dec 8, 2025 | Gregory T. Lucierdirector | Purchase | 48,528 | $3.67 | 155,123 |
| Nov 13, 2025 | Bernd Brustdirector, officer: Chief Executive Officer | Purchase | 216,212 | $3.25 | 466,771 |
| Nov 11, 2025 | Bernd Brustdirector, officer: Chief Executive Officer | Purchase | 157,201 | $3.24 | 157,201 |
| Nov 12, 2025 | Bernd Brustdirector, officer: Chief Executive Officer | Purchase | 93,358 | $3.21 | 250,559 |
CongressHouse and Senate disclosures
Not reported.